O'DAY DANIEL PATRICK (Chairman & CEO) sold 2.4% of their position (15K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $1.97M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/2/2026ACC: 0001638643-26-000022
DirectorOfficer· Chairman & CEO
Since Feb 2019
-15K
Net shares
Net seller
$1.97M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.90K
Price / share
$131.10
Trade value
$1.43M
% of position
1.7%
6/1/2026
632.57K→621.67K
Common Stock
Direct
Shares
−3.06K
Price / share
$132.22
Trade value
$404.84K
% of position
0.5%
6/1/2026
621.67K→618.61K
Common Stock
Direct
Shares
−1.04K
Price / share
$132.97
Trade value
$138.02K
% of position
0.2%
6/1/2026
618.61K→617.57K
Total
Net shares
−15K
Net value
-$1.97M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −10.90K | $131.10 | $1.43M | 1.7% | 632.57K | 621.67K |
| Common Stock Direct | 6/1/2026 | S · Sale | −3.06K | $132.22 | $404.84K | 0.5% | 621.67K | 618.61K |
| Common Stock Direct | 6/1/2026 | S · Sale | −1.04K | $132.97 | $138.02K | 0.2% | 618.61K | 617.57K |
| Total | −15K | -$1.97M | ||||||
Derivative Transactions0
No derivative transactions reported